GB0817429D0 - Enzyme inhibitors - Google Patents

Enzyme inhibitors

Info

Publication number
GB0817429D0
GB0817429D0 GBGB0817429.4A GB0817429A GB0817429D0 GB 0817429 D0 GB0817429 D0 GB 0817429D0 GB 0817429 A GB0817429 A GB 0817429A GB 0817429 D0 GB0817429 D0 GB 0817429D0
Authority
GB
United Kingdom
Prior art keywords
enzyme inhibitors
inhibitors
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0817429.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Argenta Discovery Ltd
Original Assignee
Argenta Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argenta Discovery Ltd filed Critical Argenta Discovery Ltd
Priority to GBGB0817429.4A priority Critical patent/GB0817429D0/en
Publication of GB0817429D0 publication Critical patent/GB0817429D0/en
Priority to PCT/GB2009/002278 priority patent/WO2010034996A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
GBGB0817429.4A 2008-09-23 2008-09-23 Enzyme inhibitors Ceased GB0817429D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0817429.4A GB0817429D0 (en) 2008-09-23 2008-09-23 Enzyme inhibitors
PCT/GB2009/002278 WO2010034996A1 (en) 2008-09-23 2009-09-23 Crystalline acid addition salts and their use as enzyme inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0817429.4A GB0817429D0 (en) 2008-09-23 2008-09-23 Enzyme inhibitors

Publications (1)

Publication Number Publication Date
GB0817429D0 true GB0817429D0 (en) 2008-10-29

Family

ID=39952079

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0817429.4A Ceased GB0817429D0 (en) 2008-09-23 2008-09-23 Enzyme inhibitors

Country Status (2)

Country Link
GB (1) GB0817429D0 (en)
WO (1) WO2010034996A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114650819A (en) 2019-09-17 2022-06-21 美莱奥生物制药第四有限公司 Avermectistat for treating graft rejection, bronchiolitis obliterans syndrome and graft-versus-host disease
IL297211A (en) 2020-04-16 2022-12-01 Mereo Biopharma 4 Ltd Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
AU2022373971A1 (en) 2021-10-20 2024-04-04 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0711169A2 (en) * 2006-05-04 2011-08-23 Argenta Discovery Ltd tetrahydropyrrolopyridinediones and their use as human neutrophil elastase inhibitors

Also Published As

Publication number Publication date
WO2010034996A1 (en) 2010-04-01

Similar Documents

Publication Publication Date Title
GB0619753D0 (en) Enzyme inhibitors
IL194339A0 (en) Enzyme inhibitors
ZA201100898B (en) Novel inhibitors
WO2009151920A9 (en) Hepsin inhibitors
GB0811091D0 (en) CYP26 Inhibitors
GB0608844D0 (en) Enzyme inhibitors
ZA201102837B (en) Phosphodiestarase inhibitors
ZA201102179B (en) Protease inhibitors
GB0804721D0 (en) Enzyme
GB0818328D0 (en) Novel enzyme
GB0617161D0 (en) Enzyme inhibitors
GB0803628D0 (en) Enzyme
EP2222662A4 (en) Kynurenine-aminotransferase inhibitors
GB0817429D0 (en) Enzyme inhibitors
GB0804722D0 (en) Enzyme
GB0817425D0 (en) Protease inhibitors
GB0812443D0 (en) Enzyme inhibitors
GB0807056D0 (en) Enzyme inhibitors
GB0706853D0 (en) Enzyme inhibitors
GB0721868D0 (en) eNZYME INHIBITORS
GB0901616D0 (en) Enzyme inhibitors
GB0908068D0 (en) Enzyme inhibitors
GB0803284D0 (en) Enzyme inhibition
GB0803283D0 (en) Enzyme inhibition
GB0904936D0 (en) Enzyme inhibitor

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)